MSB 10.4% $1.49 mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-283

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,001 Posts.
    lightbulb Created with Sketch. 315
    In the simplest terms, if sick people get better, if trials meet endpoints, you can know its consistent enough. You cant have good trial outcomes if the product is all over the place. Another trial will hopefully confirm that beyond debate. There are potency essays/markers. I believe MSB have put forth a "cartoon" on how, in MSB view, how its believed to work. This MOA has not been proven without doubt, yet there are plenty of drugs being sold that have no known MOA.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.49
Change
0.140(10.4%)
Mkt cap ! $1.701B
Open High Low Value Volume
$1.37 $1.54 $1.37 $23.10M 15.82M

Buyers (Bids)

No. Vol. Price($)
3 24758 $1.49
 

Sellers (Offers)

Price($) Vol. No.
$1.49 73626 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.